SCHEMBL20433293

SCHEMBL20433293

Cc1ccc(-c2cnc(N)c(C3OC(c4ccccc4)=NN3C)n2)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ATR Q13535 7/20 0.38
▸ MAOB P27338 3/20 0.35
▸ PRKDC P78527 1/20 0.31
▸ HSD11B1 P28845 1/20 0.31
▸ CSF1R P07333 1/20 0.31
▸ DPP4 P27487 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ PPARG P37231 1/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ NR2E3 Q9Y5X4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20433339 0.80 ATR (0.42) ATRMAOBKDM4EPOLBPPARG
SCHEMBL20433069 0.78 ATR (0.47) ATRKDM4ECYP3A4CYP2C9CYP2C19
SCHEMBL24681201 0.78 ATR (0.47) ATR
SCHEMBL20433475 0.77 ATR (0.53) NPC1ATR
SCHEMBL20433177 0.76 ATR (0.55) ATRMAOBPRKDCADORA1
SCHEMBL20433561 0.74 ATR (0.38) ATRPRKDC
SCHEMBL20433492 0.74 ATR (0.52) ATRMAOBPRKDC
SCHEMBL20433040 0.74 ATR (0.53) ATRPRKDCADORA1
SCHEMBL24681760 0.74 ATR (0.38) NPC1RAB9AATR
SCHEMBL20433365 0.72 ATR (0.54) NPC1RAB9AHPGDNPSR1ATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4059932-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2022-09-21 — — EP disclosed
EP-3354650-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2018-08-01 — — EP disclosed
Send feedback